Lilly Launches World's First Nvidia DGX B300 SuperPOD for AI Drug Discovery
Lilly has launched the LillyPod, the first Nvidia DGX B300 SuperPOD, at its Indianapolis headquarters. The system, featuring 1,016 Nvidia Blackwell Ultra GPUs, delivers over 9,000 petaflops of AI performance to enhance drug discovery, genomics, and personalized medicine. The supercomputer is designed to enable rapid model training and will operate on 100% renewable electricity by 2030. Lilly aims to use the system for internal projects, including chatbot development and research workflows.
Theia Market Signal Identification - AI Assisted
Lilly has introduced the LillyPod, the first Nvidia DGX B300 SuperPOD, at its headquarters in Indianapolis. Assembled in four months, the system features 1,016 Nvidia Blackwell Ultra GPUs, providing over 9,000 petaflops of AI performance.
It will be utilized to train models aimed at accelerating drug discovery timelines and breakthroughs in genomics and personalized medicine. Lilly intends for the supercomputer to run on 100% renewable electricity by 2030, employing efficient cooling methods. The system will also support internal applications, including chatbots and research agents.
Comments